Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
CPTx Logo
CPTx Growth Score
84
CB Rank
34329
Heat Score
69
CPTx develops single-stranded DNA products to neutralize viruses and address infectious diseases.
Founded
obfuscation
PrivateVenture - Series Unknown Planegg, Bayern, Germany11-50 www.cptx.bio
Biotechnology
Genetics
Test and Measurement
Overview

CPTx
Total Funding
obfuscation
Growth Score
84
Heat Score
69

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score84
-6 pts
in past quarter
Heat Score 69
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About CPTx

CB Rank
34329
CPTx develops single-stranded DNA products to neutralize viruses and address infectious diseases.
Founded
obfuscation
PrivateVenture - Series Unknown Planegg, Bayern, Germany11-50 www.cptx.bio
Biotechnology
Genetics
Test and Measurement

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name CPTx GmbH
Operating Status Active
Company Type For Profit
Founders  Christian Sigl, Hendrik Dietz
Phone Number +49 089 6933 0382
Contact Email info@cptx.bio
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

In Vivo CAR-T Platform Program
A genetic therapy platform using single-stranded DNA to produce CAR-T cells inside the body for treating cancer and autoimmune diseases.
Self-Delivering Gene Carrier Technology
A proprietary single-stranded DNA-based gene delivery system designed to improve gene therapy accessibility and overcome limitations of existing delivery methods.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - CPTx Logo
Venture Round - CPTx
7
obfuscation
BlueYard Capital, SPRIN-DVenture - Series Unknown
obfuscation
Venture Round - CPTx Logo
Venture Round - CPTx
7
obfuscation
BlueYard Capital, SPRIN-DVenture - Series Unknown
obfuscation
Venture Round - CPTx Logo
Venture Round - CPTx
7
obfuscation
BlueYard Capital, SPRIN-DVenture - Series Unknown
obfuscation
Venture Round - CPTx Logo
Venture Round - CPTx
7
obfuscation
BlueYard Capital, SPRIN-DVenture - Series Unknown
obfuscation
Venture Round - CPTx Logo
Venture Round - CPTx
7
obfuscation
BlueYard Capital, SPRIN-DVenture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - CPTx Logo
Venture Round - CPTx
7
obfuscation
BlueYard Capital, SPRIN-DVenture - Series Unknown
obfuscation
Venture Round - CPTx Logo
Venture Round - CPTx
7
obfuscation
BlueYard Capital, SPRIN-DVenture - Series Unknown
obfuscation
Venture Round - CPTx Logo
Venture Round - CPTx
7
obfuscation
BlueYard Capital, SPRIN-DVenture - Series Unknown
obfuscation
Venture Round - CPTx Logo
Venture Round - CPTx
7
obfuscation
BlueYard Capital, SPRIN-DVenture - Series Unknown
obfuscation
Venture Round - CPTx Logo
Venture Round - CPTx
7
obfuscation
BlueYard Capital, SPRIN-DVenture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Leblon Capital Logo
Leblon Capital
—
Venture Round - CPTx Logo
Venture Round - CPTx
—
Leblon Capital Logo
Leblon Capital
—
Venture Round - CPTx Logo
Venture Round - CPTx
—
Leblon Capital Logo
Leblon Capital
—
Venture Round - CPTx Logo
Venture Round - CPTx
—
Leblon Capital Logo
Leblon Capital
—
Venture Round - CPTx Logo
Venture Round - CPTx
—
Leblon Capital Logo
Leblon Capital
—
Venture Round - CPTx Logo
Venture Round - CPTx
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 2

Employee Profiles

News

News and Press

News•Jun 17, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

737
24.49%
 in past month

IT Spend

$99.2KThis year, CPTx is projected to spend $99.2K on IT, according to Aberdeen.

Active Website Tech Count

4CPTx is actively using 4 technologies for its website, according to BuiltWith. These include Person Schema, CommonCrawl Top 5m, and  Gravatar Profiles.

Total IP

10The intellectual property of CPTx includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, CPTx has registered 8 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is CPTx's headquarters? CPTx is located in Planegg, Bayern, Germany.Who invested in CPTx? CPTx has 7 investors including Leblon Capital and  SPRIN-D.When was the last funding round for CPTx? CPTx closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are CPTx's competitors? Alternatives and possible competitors to CPTx may include Kyverna Therapeutics, Arcellx, and  Capstan Therapeutics.How much funding has CPTx raised to date? CPTx has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(790e229 1)
|